PubMed Health⌕ Search

Biomedical subjects

A Arbore

Publications and source records attributed to A Arbore.

26 records · Page 2Linked to original sources
PubMedDate not supplied

[Informational system in prevention and integrated fight against tuberculosis].

The authors have sent out a special form to a total of 50 specialists and general practitioners, and their answers it appeared that these physicians consider necessary to review and to render more technical the system used for the information in view of the prevention and the integrated fight against tuberculosis. The authors recall the fundamental technical notions in this connection and present the generators and the recipients of information related to the fight against tuberculosis, the informational flow in the anti-tuberculous activity, the standardized informational instruments of the Ministry of Health and the informational channels which are accessible in the practice. In conclusion the authors present the stocking and the transfer of anti-tuberculous information, synthesized on a functional representation of the informational system in the prevention and the integrated fight against tuberculosis.

BCG Vaccine↗
PubMedDate not supplied

[The value of bacteriological controls in the epidemiological studies of tuberculosis].

The authors make an analysis of bacteriological data concerning patients with tuberculosis from a certain area (the Jassy County) which have been recorded between 1971 and 1980. An analysis is presented of the instantaneous and of the maximal prevalence of tuberculous bacilli carriers in the urban and the rural environments, and the incidence of tuberculosis in children and adults, also in the urban and the rural media. Some other aspects are studied of primary drug resistance, as well as of secondary resistance. The data presented in the paper stress the major role of the bacteriological investigation in the epidemiological follow-up of tuberculosis, as well as the fact that bacteriological indicators are capable to evidence essential aspects of the evolution of tuberculosis endemia in a certain area.

Age Factors↗
PubMedDate not supplied

[Evolution of chronic pulmonary tuberculosis and the possibility of preventing chronicization (in the Iaşi judicial district)].

The instantaneous prevalence of patients with pulmonary tuberculosis has been evaluated; the patients were included in the dispensarization group I between 1974 and 1980. Initially there was a decrease of the prevalence of the patients in Group I B but over the last years this was stable at 11.7-13.5 0/0000 inhabitants. The decrease which had been obtained at first was due to the immediate effect of repeated treatments with new tuberculostatic drugs resulting in sterilization and inclusion in the Group II of dispensarization of many of the preexisting patients while the ceiling which occurred later was determined by the quantitative balance of therapeutic failures and relapses entering the Group I B and cases which left the Group as a result of medical solutions, death or change of address. It was also noted that most of the patients in whom presence of the bacilli had been determined by microscopic techniques and by cultures constituted a relatively stable group over the entire period of the study, and oscillated between 11 and 17.5%, and 56.5 and 65.9% respectively. The quantitative balance established over the last years between the "entrances" and the "exits" from Group I B may be altered firstly by lowering the number of failures and relapses after the first treatment. The nature of unfavourable factors which influence the prognosis may be classified as follows: bio-psycho-social implications (males--81.5%, age--between 30 and 50 years, 51.4%, lack of occupation, 31.5%, low educational level, 80.1% chronic ethyl intoxication 51.4%, psychoses, 12.7%, other associated diseases, 34.3%, and primary drug resistance, 7.1%); consequences of a late detection; deficiencies in the rhythm and the duration of the first treatment with tuberculostatic drugs (non-cooperation--64.2%, irregularities--38.5%, interruptions--42.8%, secondary drug resistance--14.2%).

Adult↗